Total and free plasma neuroleptic levels in schizophrenic patients.
Nineteen male patients, under 35 years of age, newly admitted with a diagnosis of schizophrenia, were treated with either chlorpromazine or haloperidol at a fixed dosage for 25 days. Both total and free plasma neuroleptic levels were measured using a radioreceptor assay. Clinical response was measured by the Brief Psychiatric Rating Scale (BPRS). On day 25, nonresponders (those with a decrease of less than 8 points on the BPRS) had both total and free plasma neuroleptic levels within the range observed in responders. It is therefore concluded that lack of therapeutic response is generally not due to inadequate plasma drug levels.
D000328:Adult; D002746:Chlorpromazine / Q000097:blood* / Q000627:therapeutic use; D006220:Haloperidol / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008297:Male; D011569:Psychiatric Status Rating Scales; D011869:Radioligand Assay; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy; D012565:Schizophrenic Psychology
D006220:Haloperidol; D002746:Chlorpromazine